Drugs for Mucocutaneous Leishmaniasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 23)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
meglumine antimoniate |
|
Phase 2, Phase 3 |
|
|
|
2 |
|
Anti-Infective Agents |
|
Phase 2, Phase 3,Phase 1 |
|
|
|
3 |
|
Antiprotozoal Agents |
|
Phase 2, Phase 3,Phase 1 |
|
|
|
4 |
|
Antiparasitic Agents |
|
Phase 2, Phase 3,Phase 1 |
|
|
|
5 |
|
Amphotericin B |
Approved, Investigational |
Phase 1, Phase 2 |
|
1397-89-3 |
5280965
14956
|
Synonyms:
12633-72-6
1397-89-3
30782-62-8
5-18-10-00525 (Beilstein Handbook Reference)
54482-28-9
8055-20-7
AB00513832
Abelcet
Abelecet
ABLC
AC1L1CN2
AC1L24V6
AC1L70KF
AC1L73U6
AC1NQXTD
AC1NTQ32
AC1NUQG4
AC1NY9JC
AC1O7GCZ
AC1O8FQV
AC1O8PFK
AI3-26528
Ambap1397-89-3
Ambisome
AmBisome (TN)
Amfotericina B
Amfotericina B [INN-Spanish]
amophotericin B
AMPH-b
AMPH-B
Amphocin
Amphomoronal
Ampho-Moronal
Amphortericin B
Amphotec
Amphotec (TN)
Amphotericin
Amphotericin .BETA.
amphotericin b
Amphotericin B
Amphotericin B (JP15/USP/INN)
Amphotericin B [USAN:INN:JAN]
Amphotericin B Cholesterol Dispersion
Amphotericin B Colloidal Dispersion
amphotericin B liposomal
Amphotericin B, Lipid-based
Amphotericin B, Streptomyces sp.
Amphotericin-B
Amphotericine B
Amphotéricine B
Amphotericine B [INN-French]
Amphotericinum
Amphotericinum B
Amphotericinum B [INN-Latin]
Amphotherizin
Amphotherizin [German]
Amphozone
BIDD:GT0351
BPBio1_000374
BRN 0078342
BSPBio_000340
C06573
C47H73NO17
C-AmB
CCRIS 5963
CHEBI:2682
CHEMBL1200646
CHEMBL267345
CID10533925
CID10629638
CID10677275
|
CID14956
CID1972
CID352546
CID354192
CID5280965
CID5386092
CID5458486
CID5771695
CID6604295
CID6708817
CID6713692
CID9919339
D00203
DB00681
DivK1c_007045
EINECS 215-742-2
Fungilin
Fungisome
Fungisone
Fungizone
Fungizone (TN)
Halizon
HMS1569A22
HSDB 3008
HSDB 3008 IAB
I06-0257
KBio1_001989
KBio2_000551
KBio2_003119
KBio2_005687
KBioGR_002298
KBioSS_000551
Liposomal amphotericin b
Liposomal Amphotericin B
LMPK06000002
LNS-AmB
LS-187721
LS-93
MLS002702966
MolPort-006-392-260
Mysteclin-F
NCGC00014913
NCGC00090808-01
NCGC00098014-01
NCGC00179595-01
NCI527017
NCI60_004288
NCIStruc1_001042
NCIStruc2_000920
NKTR-024
NS 718
NSC 527017
NSC527017
NSC-527017
Prestwick_721
Prestwick0_000410
Prestwick1_000410
Prestwick2_000410
Prestwick3_000410
SinuNase
SMP1_000302
SMR001566780
SPBio_000715
SPBio_002279
SpecPlus_000949
Spectrum_000111
Spectrum2_000818
Spectrum4_001779
ST50999656
UNII-7XU7A7DROE
|
|
6 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 2,Phase 1 |
|
22916-47-8 |
4189
|
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
Aflorix(nitrate)
AKOS001574474
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
Conofite(nitrate)
CPD-4501
D00416
Dactarin
Daktarin iv
Daktarin IV
DB01110
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
Lotrimin AF(nitrate)
LS-78378
MCZ
Micantin (nitrate)
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
|
miconazole
Miconazole
Miconazole (JP15/USP/INN)
Miconazole [USAN:BAN:INN:JAN]
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MJR 1762
MLS002222203
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (tn)
Monistat iv (TN)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
Novo-Miconazole Vaginal Ovules
NSC 170986
NSC169434
NSC170986
Oprea1_091955
Prestwick_335
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
Spectrum_000965
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
STK834405
STOCK1S-93556
UNII-7NNO0D7S5M
Vusion
Zimycan
|
|
7 |
|
Miltefosine |
Approved, Investigational |
Phase 2,Phase 1 |
|
58066-85-6 |
3600
|
Synonyms:
1-Hexadecylphosphorylcholine
2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt
3,5-Dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide
4-04-00-01460 (Beilstein Handbook Reference)
58066-85-6
AC1L1GAH
Baxter brand of miltefosine
Baxter Oncology brand of miltefosine
BRN 3690495
C039128
C15H32.C7H17NO4P
CHEBI:125047
CHEMBL125
Choline hydroxide, hexadecyl hydrogen phosphate, inner salt
Choline phosphate, hexadecyl ester, hydroxide, inner salt
Choline phosphate, hexadecyl ester, hydroxide, inner salt (6CI)
Choline, hexadecyl hydrogen phosphate, inner salt
CID3599
D 18506
D02494
D18506
D-18506
Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt
Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, innner salt
H-1850
HDPC
HePC
Hexadecyl 2-(trimethyl-.lambda.~5~-azanyl)ethyl hydrogen phosphate
hexadecyl 2-(trimethylazaniumyl)ethyl phosphate
Hexadecylphosphocholine
Hexadecylphosphorylcholine
|
HMS1922D16
HMS2089J15
I14-7244
Impavido
IN1227
LS-65132
M-7200
Miltefosin
Miltefosin C
Miltefosina
Miltefosina [INN-Spanish]
Miltefosine
Miltéfosine
Miltefosine (INN)
Miltefosine [INN:BAN]
Miltefosinum
Miltefosinum [INN-Latin]
Miltex
MolPort-003-665-519
Monohexadecylphosphocholine
Monohexadecylphosphorylcholine
NCGC00095169-01
NCGC00095169-02
NCGC00095169-03
n-Hexadecylphosphorylcholine
NSC605583
Prasfarma brand of miltefosine
SPECTRUM1505329
ST51055612
TF-002
UNII-53EY29W7EC
|
|
8 |
|
Coal tar |
Approved |
Phase 2 |
|
8007-45-2 |
|
Synonyms:
|
9 |
|
Pentoxifylline |
Approved, Investigational |
Phase 2 |
|
6493-05-6 |
4740
|
Synonyms:
1-(5-Oxohexyl)-3,7-dimethylxanthine
1-(5-Oxohexyl)theobromine
1,2,3,6-Tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion
2a3c
3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl) xantine
3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxo-hexyl)-3,7-dihydro-purine-2,6-dione
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)xanthine
3,7-Dimethyl-1-(5-oxohexyl)xantine
5-26-14-00081 (Beilstein Handbook Reference)
6493-05-6
AB00052363
AC1L1IUN
Agapurin
Agapurin Retard
AKOS000541484
Azupentat
BAS 00897429
BB_SC-2111
BIDD:GT0174
BL 191
BL191
BL-191
BPBio1_000167
BRD-K57569181-001-05-1
BRN 0558929
BSPBio_000151
BSPBio_003439
C07424
C13H18N4O3
CAS-1677687
CCRIS 6832
CHEMBL628
CID4740
cis-9-Octadecenoyl coenzyme A
CPD000035998
D00501
D010431
DB00806
Dimethyloxohexylxanthine
DivK1c_000729
Durapental
EHT 0201
EHT0201
EHT-0201
EHT-201
EINECS 229-374-5
EU-0100936
Hemovas
HMS1568H13
HMS1922E16
HMS2051N06
HMS2090H13
HMS2093G21
HMS502E11
I06-1592
IDI1_000729
Ikomio
IN1161
KBio1_000729
KBio2_001924
KBio2_004492
KBio2_007060
KBio3_002942
KBioGR_000893
KBioSS_001924
Lopac0_000936
|
Lopac-P-1784
LS-149385
MLS000079026
MLS000758298
MLS001201764
MolPort-001-823-263
NCGC00015801-01
NCGC00015801-02
NCGC00015801-04
NCGC00015801-10
NCGC00067069-02
NCGC00067069-03
NCGC00067069-04
NCGC00067069-05
NCGC00178062-01
NCGC00178062-02
NINDS_000729
NSC 637086
NSC637086
Oxpentifylline
P 1784
PDSP1_001015
PDSP2_000999
Pentoxifilina
Pentoxifilina [INN-Spanish]
Pentoxifyllin
pentoxifylline
Pentoxifylline
Pentoxifylline (JAN/USP/INN)
Pentoxifylline [USAN:INN:JAN]
Pentoxifyllinum
Pentoxifyllinum [INN-Latin]
Pentoxil
Pentoxil (TN)
Pentoxiphyllin
Pentoxiphylline
Pentoxiphyllium
Pentoxyfylline
PENTOXYPHYLINE
Pentoxyphyllin
Pentoxyphylline
PNX
Prestwick_608
Prestwick0_000196
Prestwick1_000196
Prestwick2_000196
Prestwick3_000196
Px
Ralofect
Rentylin
SAM001247011
SMR000035998
SPBio_001221
SPBio_002072
Spectrum_001444
SPECTRUM1503611
Spectrum2_001181
Spectrum3_001820
Spectrum4_000227
Spectrum5_001161
SR-01000075641-4
STK177321
Torental
Trental
Trental (TN)
UNII-SD6QCT3TSU
Vasofirin
Vazofirin
ZINC01530776
|
|
10 |
|
Anthelmintics |
|
Phase 1, Phase 2 |
|
|
|
11 |
|
Antifungal Agents |
|
Phase 2,Phase 1 |
|
|
|
12 |
|
Antimony Sodium Gluconate |
|
Phase 1, Phase 2 |
|
|
|
13 |
|
Liposomal amphotericin B |
|
Phase 1, Phase 2 |
|
|
|
14 |
|
Vasodilator Agents |
|
Phase 2 |
|
|
|
15 |
|
Phosphodiesterase Inhibitors |
|
Phase 2 |
|
|
|
16 |
|
Platelet Aggregation Inhibitors |
|
Phase 2 |
|
|
|
17 |
|
Protective Agents |
|
Phase 2 |
|
|
|
18 |
|
Radiation-Protective Agents |
|
Phase 2 |
|
|
|
19 |
|
Antioxidants |
|
Phase 2 |
|
|
|
20 |
|
Vaccines |
|
Phase 1 |
|
|
|
21 |
|
Cortisone acetate |
Approved, Investigational |
|
|
1950-04-4, 50-04-4 |
5745
|
Synonyms:
|
22 |
|
Cortisone |
|
|
|
53-06-5 |
222786
|
Synonyms:
Andreson
Anusol HC
Balneol-Hc
beta-Hc
Colocort
Compound E
Corlin
Cortadren
Cortandren
Cortef
Cortef Acetate
Cortisal
Cortisate
Cortison
Cortisone Acetate
Cortistal
Cortivite
Cortogen
Cortone
Cortril
Dermacort
Dricort
Flexicort
|
Florinef
Fludrocortisone Acetate
Glycort
Hemsol-Hc
Hi-Cor
Incortin
Kendall'S compound
Kendall'S Compound E
Locoid
Locoid Lipocream
Micort-Hc
Nogenic HC
Orabase HCA
Pandel
Prestwick_132
Reichstein Fa
Reichstein'S Substance FA
Scheroson
Solu-Cortef
Stie-Cort
Texacort
Westcort
|
|
23 |
|
Anti-Inflammatory Agents |
|
|
|
|
|
Interventional clinical trials:
(show all 15)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Low Antimonial Dosage in American Mucosal Leishmaniasis |
Recruiting |
NCT01301937
|
Phase 2, Phase 3 |
Meglumine antimoniate |
2 |
Miltefosine to Treat Mucocutaneous Leishmaniasis |
Completed |
NCT01050907
|
Phase 2 |
miltefosine |
3 |
Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis |
Completed |
NCT01377974
|
Phase 2 |
Miltefosine;Standard Treatment Meglumine antimoniate |
4 |
Miltefosine for Mucosal Leishmaniasis |
Completed |
NCT00373776
|
Phase 1, Phase 2 |
miltefosine 2.5 mg/kg/day for 28 days |
5 |
Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis |
Completed |
NCT00373568
|
Phase 1, Phase 2 |
miltefosine: 2.5 mg/kg/day for 42 days |
6 |
Use of Sodium Stibogluconate as a Treatment for Leishmaniasis |
Completed |
NCT00657618
|
Phase 1, Phase 2 |
Sodium Stibogluconate (SSG) |
7 |
Sodium Stibogluconate Treatment of Leishmaniasis |
Completed |
NCT00662012
|
Phase 2 |
Sodium Stibogluconate (SSG) |
8 |
Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia |
Completed |
NCT00233545
|
Phase 2 |
miltefosine;antimony |
9 |
The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil |
Recruiting |
NCT02530697
|
Phase 2 |
Meglumine antimoniate;Miltefosine;Pentoxifylline |
10 |
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis |
Completed |
NCT00111514
|
Phase 1 |
|
11 |
Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis |
Recruiting |
NCT02429518
|
|
Miltefosine |
12 |
Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis |
Recruiting |
NCT02431429
|
|
Miltefosine |
13 |
Cortisone and QTc-Interval |
Recruiting |
NCT03082339
|
|
|
14 |
Diagnosis and Treatment of Leishmanial Infections |
Recruiting |
NCT00344188
|
|
|
15 |
Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis |
Available |
NCT00508963
|
|
sodium stibogluconate (Pentostam) |
|